Extracellular microvesicles from patients with Rheumatoid arthritis promote dendritic cell activation in vitro

Area of Science:

• Immunology
• Rheumatology

Background:

• Rheumatoid Arthritis (RA) is a chronic autoimmune disease causing joint inflammation and destruction.
• Dendritic cells (DCs) play a key role in immune responses, including autoimmune diseases like RA.
• Extracellular microvesicles (EMVs) are implicated in RA pathogenesis by carrying antigens.

Purpose of the Study:

• To investigate whether EMVs from RA patients can activate immature monocyte-derived DCs.
• To determine if EMVs induce phenotypic and functional maturation of DCs.

Main Methods:

• EMVs were isolated from RA patients naive to disease-modifying anti-rheumatic drugs (DMARDs).
• EMVs were used to treat DCs from healthy donors.
• DC maturation was assessed via surface marker expression (CD83, CD86, HLA-DR, CD80) and cytokine production (IL-12, IL-1β, IL-10).
• Western blot confirmed the presence of carbamylated and citrullinated proteins in EMVs.

Main Results:

• EMVs from RA patients contain carbamylated and citrullinated proteins.
• EMV-treated DCs showed increased expression of maturation markers (CD83, CD86, HLA-DR, CD80).
• EMVs induced activation of MAPK and NF-κB signaling pathways in DCs.
• EMVs stimulated DCs to produce pro-inflammatory cytokines IL-12, IL-1β, and IL-10.

Conclusions:

• EMVs from RA patients promote DC activation and maturation in vitro.
• This suggests a mechanism by which the RA microenvironment perpetuates inflammation via DC modulation.
• EMVs represent a potential therapeutic target for RA.